Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Zolkind

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2019
Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T CellsJay Friedman, Ellen C Moore, Paul Zolkind, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 28, 2025
Patient-Reported Swallowing Outcomes in HPV+ Oropharyngeal Cancer by Postoperative Chemoradiation Dose in MINT and E3311Theresa Tharakan, Sidharth V Puram, Randal C Paniello, et al.
Cell Reports|August 23, 2018
Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular HeterogeneityKatie M Campbell, Tianxiang Lin, Paul Zolkind, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell CarcinomasTenny Mudianto, Katie M Campbell, Jason Webb, et al.
Cancers|October 14, 2023
Immune Cell Deconvolution Reveals Possible Association of γδ T Cells with Poor Survival in Head and Neck Squamous Cell CarcinomaAnuraag S Parikh, Yize Li, Angela Mazul, et al.
Oral Oncology|August 31, 2025
Management of HPV+ head and neck squamous cell carcinoma with unknown primary in the era of treatment de-escalationThomas F Barrett, Anthony J Apicelli, Salma Ramadan, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 19, 2025
Long-Term Outcomes After Elective Contralateral Neck Dissection for HPV-Related Oropharyngeal CancerRay Y Wang, Molly E Heft Neal, Wade L Thorstad, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 1, 2025
Long-Term Outcomes of Patients With HPV+ Unknown Primary Squamous Cell Carcinoma Treated With Transoral SurgeryThomas F Barrett, Adam Boukind, Kwasi Enin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical TrialRavindra Uppaluri, Ashley E Winkler, Tianxiang Lin, et al.
Journal for Immunotherapy of Cancer|January 21, 2022
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer respondersLiye Zhou, Zexian Zeng, Ann Marie Egloff, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2019
Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T CellsJay Friedman, Ellen C Moore, Paul Zolkind, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 28, 2025
Patient-Reported Swallowing Outcomes in HPV+ Oropharyngeal Cancer by Postoperative Chemoradiation Dose in MINT and E3311Theresa Tharakan, Sidharth V Puram, Randal C Paniello, et al.
Cell Reports|August 23, 2018
Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular HeterogeneityKatie M Campbell, Tianxiang Lin, Paul Zolkind, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell CarcinomasTenny Mudianto, Katie M Campbell, Jason Webb, et al.
Cancers|October 14, 2023
Immune Cell Deconvolution Reveals Possible Association of γδ T Cells with Poor Survival in Head and Neck Squamous Cell CarcinomaAnuraag S Parikh, Yize Li, Angela Mazul, et al.
Oral Oncology|August 31, 2025
Management of HPV+ head and neck squamous cell carcinoma with unknown primary in the era of treatment de-escalationThomas F Barrett, Anthony J Apicelli, Salma Ramadan, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 19, 2025
Long-Term Outcomes After Elective Contralateral Neck Dissection for HPV-Related Oropharyngeal CancerRay Y Wang, Molly E Heft Neal, Wade L Thorstad, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 1, 2025
Long-Term Outcomes of Patients With HPV+ Unknown Primary Squamous Cell Carcinoma Treated With Transoral SurgeryThomas F Barrett, Adam Boukind, Kwasi Enin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical TrialRavindra Uppaluri, Ashley E Winkler, Tianxiang Lin, et al.
Journal for Immunotherapy of Cancer|January 21, 2022
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer respondersLiye Zhou, Zexian Zeng, Ann Marie Egloff, et al.
Pageof 4